http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-367372-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd8ac7245ce4387bce8bb9858c0f81c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99fa6befec4b45a34225b06ff23bfeec
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-36
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-36
filingDate 1969-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1972-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-367372-A1
titleOfInvention PROCEDURE FOR OBTAINING NEW DERIVATIVES WITH ANTI-INFLAMMATORY ACTION, CONSTITUTED BY ENOLATES OF AMINES FROM THE BENCIDAMINE SERIES WITH PHENYLBUTAZONE, P-HI-DROXIFENILBUTAZONE AND CETOFENILBOTAZONA.
abstract Procedure for obtaining new derivatives with anti-inflammatory action, consisting of amine enolates of the benzidamine series with phenylbutazone, p-hydroxyphenylbutazone and ketophenylbutazone, of general formula **(See formula)** where R and R1 represent low molecular weight hydrogens or alkyl moieties, which may be the same or different, R2 a hydrogen or a hydroxyl moiety, and R3 an oxygen atom or two hydrogen atoms, characterized by reacting phenylbutazone or one of its derivatives p-hydroxylated or gamma-ketone with indazole amine hydrochloride in the presence of an equivalent of a strong inorganic or organic base. (Machine-translation by Google Translate, not legally binding)
priorityDate 1969-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420235488
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3824
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12555
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484695

Total number of triples: 30.